𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

✍ Scribed by Fritz Jänicke; Anfred Hölscher; Walther Kuhn; Rene Von Hugo; Lothar Pache; Jörg Rüdiger Siewert; Henner Graef

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
673 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is breast cancer survival improving? : T
Is breast cancer survival improving? : Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
✍ Sharon H. Giordano; Aman U. Buzdar; Terry L. Smith; Shu-Wan Kau; Ying Yang; Gabr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract ## BACKGROUND Despite advances in therapies for breast cancer, improvement in survival for patients with recurrent or metastatic breast cancer has been difficult to establish. The objective of the current study was to determine whether the survival of women with recurrent breast cancer

Decreased intraperitoneal disease recurr
Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival
✍ Angèle L. Oei; René H. Verheijen; Michael V. Seiden; Benedict B. Benigno; Albert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 171 KB

## Abstract This study analyzes the site of disease recurrence in ovarian cancer patients to assess the influence of a single intraperitoneal (IP) administration of yttrium‐90‐labeled murine monoclonal antibody HMFG1 (^90^Y‐muHMFG1) on the pattern of disease recurrence. In a large phase III trial o

Cancer-specific survival and predictors
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy
✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme

Surgery in recurrent epithelial ovarian
Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction
✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a

Low drug resistance to both platinum and
Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer
✍ Koji Matsuo; Virginia K. Bond; Michele L. Eno; Dwight D. Im; Neil B. Rosenshein 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract The objective of this study was to evaluate the role of an __in vitro__ drug resistance assay to platinum and taxane in the management of advanced epithelial ovarian, fallopian and primary peritoneal cancer. All patients with FIGO Stage IIIc and IV who received postoperative chemotherap